JmjC-KDMs as Metabolism-Sensitive Epigenetic Rheostats: Context-Dependent Chromatin Remodeling in MASLD Progression
Biomolecules · 16.11.2026 · 16 (11) · 1664
DOI: 10.3390/biom16111664 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 16.11.2026. Verfasst von Weiliang Zhang und 7 weiteren Autor:innen. Die Arbeit nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Nantong Science and Technology Project, Postgraduate Research & Practice Innovation Program of Jiangsu Province.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) progresses from simple steatosis to metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, cirrhosis and hepatocellular carcinoma (HCC). Although metabolic stress is recognized as a central driver of MASLD initiation, the mechanisms by which early metabolic injury is converted into persistent inflammatory, fibrotic and oncogenic transcriptional programs remain incompletely defined. In particular, a conceptual framework linking altered metabolic cues to chromatin-associated molecular signatures is still lacking. Jumonji C domain-containing histone lysine demethylases (JmjC-KDMs) are Fe(II)/α-ketoglutarate-dependent dioxygenase enzymes, placing them at a critical interface between metabolic perturbation and epigenetic remodeling. In this review, we summarize current evidence for the functional roles of JmjC-KDMs across the MASLD continuum, with particular emphasis on mechanistic links between JmjC-KDM dysregulation and metabolic dysfunction, inflammation, immune remodeling, fibrosis and hepatocarcinogenesis. We propose that JmjC-KDMs function as context-dependent epigenetic rheostats, with their effects shaped by metabolic cofactors, cell type, disease stage, substrate specificity and catalytic/non-catalytic functions. Finally, we discuss how this framework may inspire biomarker-guided, disease-stage- and cell-type-specific epigenetic strategies for MASLD.
Förderung
- National Natural Science Foundation of China
- Nantong Science and Technology Project
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
Zitieren
APA
Zhang, W., Li, T., Di, H., Wang, C., Pan, J., Zhao, J., Hu, B., & Wan, C. (2026). JmjC-KDMs as Metabolism-Sensitive Epigenetic Rheostats: Context-Dependent Chromatin Remodeling in MASLD Progression. Biomolecules, 16(11), 1664. https://doi.org/10.3390/biom16111664
Vancouver
Zhang W, Li T, Di H, Wang C, Pan J, Zhao J, et al. JmjC-KDMs as Metabolism-Sensitive Epigenetic Rheostats: Context-Dependent Chromatin Remodeling in MASLD Progression. Biomolecules. 2026;16(11):1664. doi:10.3390/biom16111664
BibTeX
@article{Zhang2026,
author = {Zhang, Weiliang and Li, Tianhao and Di, Haokun and Wang, Chunyue and Pan, Junyang and Zhao, Jianya and Hu, Baoying and Wan, Chunhua},
title = {JmjC-KDMs as Metabolism-Sensitive Epigenetic Rheostats: Context-Dependent Chromatin Remodeling in MASLD Progression},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {11},
pages = {1664},
doi = {10.3390/biom16111664}
}
EUVIMED